Clinical trial

A New Therapeutic Strategy for Urethral Sphincter Insufficiency

NCT00472069 · Assistance Publique - Hôpitaux de Paris, Other · Completed

Key facts

NCT number NCT00472069
Title A New Therapeutic Strategy for Urethral Sphincter Insufficiency
Official title EVALUATION Of A NEW THERAPEUTIC STRATEGY FOR URETHRAL SPHINCTER INSUFFICIENCY BASED ON THE INTRA-URETHRAL IMPLANTATION OF AUTOLOGOUS MYOFIBERS WITH THEIR SATELLITE CELLS
Lead sponsor Assistance Publique - Hôpitaux de Paris, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Stress Urinary Incontinence, Urethral Intrinsic Sphincter Deficiency
Intervention type Procedure
Interventions transplantation of the squeletic muscular cells
Enrollment 10
Start date Apr 1, 2007
Primary completion Feb 1, 2009
Completion Feb 1, 2009
First posted May 11, 2007
Last update posted May 5, 2011
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies